5.87
Schlusskurs vom Vortag:
$6.35
Offen:
$6.38
24-Stunden-Volumen:
21,139
Relative Volume:
0.08
Marktkapitalisierung:
$213.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.36M
KGV:
-3.5793
EPS:
-1.64
Netto-Cashflow:
$-42.09M
1W Leistung:
-5.93%
1M Leistung:
+4.26%
6M Leistung:
+170.51%
1J Leistung:
+181.01%
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Firmenname
Armata Pharmaceuticals Inc
Sektor
Branche
Telefon
310-655-2928
Adresse
4503 Glencoe Avenue, Marina del Rey, CA
Vergleichen Sie ARMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ARMP
Armata Pharmaceuticals Inc
|
5.87 | 231.18M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-19 | Eingeleitet | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Aktie (ARMP) Neueste Nachrichten
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Coverage Initiated by Analysts at Jones Trading - Defense World
Jones Trading Initiates Coverage on Armata Pharmaceuticals (ARMP - GuruFocus
Jones Trading Initiates Coverage on Armata Pharmaceuticals (NYSEAMERICAN:ARMP) - MarketBeat
Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating - Investing.com Canada
Published on: 2026-01-05 08:37:29 - moha.gov.vn
Gap Down: Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Growth Report & Risk Controlled Stock Pick Alerts - moha.gov.vn
Day Trade: Is Armata Pharmaceuticals Inc stock among top earnings playsLayoff News & Fast Exit and Entry Strategy Plans - moha.gov.vn
Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Risk Summary & Growth Focused Entry Reports - moha.gov.vn
Pharma News: Will Armata Pharmaceuticals Inc stock gain from lower inflation2025 Market WrapUp & Real-Time Buy Signal Alerts - moha.gov.vn
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% HigherStill a Buy? - MarketBeat
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% Higher – Still a Buy? - Defense World
Aug Closing: Will Armata Pharmaceuticals Inc TG1N stock benefit from sector leadershipJuly 2025 Fed Impact & Consistent Growth Equity Picks - moha.gov.vn
Is Armata Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Price Swings & Fast Moving Market Watchlists - DonanımHaber
Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatDip Buying & Safe Capital Growth Tips - Улправда
Can Armata Pharmaceuticals Inc. (TG1N) stock sustain double digit ROEJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Why Armata Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Recap & Long-Term Growth Portfolio Plans - Улправда
Armata Pharmaceuticals Earnings Notes - Trefis
Will Armata Pharmaceuticals Inc. stock pay special dividendsMarket Volume Summary & Low Risk High Win Rate Stock Picks - Улправда
Why Armata Pharmaceuticals Inc. stock attracts wealthy investors2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Will Armata Pharmaceuticals Inc. stock outperform energy sector in 2025July 2025 Setups & Advanced Technical Signal Analysis - Улправда
How Armata Pharmaceuticals Inc. stock reacts to bond yields2025 Volume Leaders & High Yield Equity Trading Tips - bolumsonucanavari.com
Will Armata Pharmaceuticals Inc. stock maintain dividend yieldJuly 2025 Setups & Smart Investment Allocation Tips - DonanımHaber
Is Armata Pharmaceuticals Inc. stock dividend growth reliableShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Merger Talk: Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Trade Review & Long-Term Growth Stock Strategies - DonanımHaber
Published on: 2025-12-19 11:47:18 - DonanımHaber
Will Armata Pharmaceuticals Inc. stock continue dividend increasesQuarterly Performance Summary & Verified Technical Signals - DonanımHaber
Can Armata Pharmaceuticals Inc. stock sustain revenue growth2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
Why Armata Pharmaceuticals Inc. (TG1N) stock is upgraded to buyCEO Change & AI Driven Stock Price Forecasts - Улправда
New Strong Sell Stocks for May 8th - sharewise.com
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year? - MSN
Free cash flow per share of Armata Pharmaceuticals, Inc. – LS:A2PKLC - TradingView
Why Armata Pharmaceuticals Inc. (TG1N) stock benefits from AI revolution2025 Big Picture & AI Forecasted Stock Moves - Newser
Is Armata Pharmaceuticals Inc. (TG1N) stock testing key supportJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser
Why Armata Pharmaceuticals Inc. (TG1N) stock attracts HNW investorsPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - MSN
Will Armata Pharmaceuticals Inc. stock announce special dividendBull Run & Real-Time Chart Breakout Alerts - Newser
Why Armata Pharmaceuticals Inc. stock is a strong buy call2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Will Armata Pharmaceuticals Inc. stock split attract more investorsJuly 2025 Patterns & Weekly Top Stock Performers List - Newser
What is the fair value estimate for Armata Pharmaceuticals Inc. stock in 2025CPI Data & Long-Term Growth Plans - Newser
Will Armata Pharmaceuticals Inc. (TG1N) stock extend growth storyEarnings Risk Summary & Long-Term Safe Return Strategies - Newser
How Armata Pharmaceuticals Inc. (TG1N) stock compares with market leadersJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Is Armata Pharmaceuticals Inc. stock considered safe havenMarket Movement Recap & Accurate Entry and Exit Point Alerts - Newser
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Shares Up 12.8%Still a Buy? - MarketBeat
Market Catalysts: Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Safe Entry Trade Reports - BỘ NỘI VỤ
Will Armata Pharmaceuticals Inc. (TG1N) stock see insider accumulationQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
How risky is Armata Pharmaceuticals Inc. stock compared to peers2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser
Will Armata Pharmaceuticals Inc. (TG1N) stock sustain dividend payoutsWeekly Trend Report & AI Based Trade Execution Alerts - Newser
Is Armata Pharmaceuticals Inc. (TG1N) stock among top earnings playsEarnings Risk Report & Fast Momentum Entry Tips - Newser
How Armata Pharmaceuticals Inc. (TG1N) stock performs during market turbulenceJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Why analysts recommend Armata Pharmaceuticals Inc. stockDividend Hike & Daily Entry Point Trade Alerts - Newser
Is Armata Pharmaceuticals Inc. stock a buy before earnings resultsAnalyst Downgrade & Weekly Watchlist for Hot Stocks - Newser
Finanzdaten der Armata Pharmaceuticals Inc-Aktie (ARMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):